Elon Musk, the world’s richest man and CEO of Tesla and SpaceX, is facing shocking allegations of heavy illegal drug use that, according to sources, not only damaged his health but may have compromised his conduct while serving in a quasi-government role under Donald Trump’s administration.
As reported by The New York Times, Musk allegedly took such large quantities of ketamine during the 2024 election campaign — while supporting Trump’s re-election — that it caused bladder damage. The report also claims the tech mogul used ecstasy and psychedelic mushrooms at private gatherings, mixing them with the dissociative anesthetic in a recreational cocktail that sources say affected his behavior and emotional stability.
Photographs reportedly show Musk carrying Adderall-labeled containers — a prescription stimulant — while exhibiting erratic conduct that deeply concerned those close to him. People within his circle described him as emotionally unstable and obsessed with fathering more children in the lead-up to the election.
Musk, 53, donated an estimated $288 million to Trump’s 2024 campaign and was considered a core figure in the former president’s inner circle. He later assumed leadership of the Department of Government Efficiency — an ad hoc cost-cutting body jokingly nicknamed “Doge.” While there, he frequently clashed with cabinet members and recently stepped down as his special government employee contract expired.
Though Musk has not publicly responded to the latest allegations, he has previously acknowledged using ketamine, claiming it was prescribed for depression. “If you use too much ketamine, you can’t really get work done,” he told Don Lemon in March. However, The New York Times reports that around the time of Trump’s comeback campaign, Musk allegedly admitted to friends that his ketamine use was harming his bladder. These claims are made even more serious by suggestions that he continued using illegal drugs such as ecstasy and mushrooms both in the U.S. and abroad.
Concerns intensified during Trump’s inauguration, where witnesses say Musk made hand gestures resembling Nazi salutes. Images from the event reportedly show Musk raising his arm during a speech — a moment that left close associates alarmed.
Musk, whose aerospace company SpaceX holds multi-billion-dollar contracts with NASA and the Pentagon, possesses “top secret” security clearance. This gives him access to some of the nation’s most sensitive classified information. According to sources, he was given advance notice of random drug tests at SpaceX, raising questions about how his drug use may have been managed or obscured within high-security environments.
Executives at Musk’s many ventures — which include Tesla, SpaceX, Neuralink, and more — have previously voiced concerns about his drug use. Neuroscientist Sam Harris stated in January that he severed ties with Musk due to concerns over his behavior and moral judgment, writing that “there is something seriously wrong with his moral compass, if not his perception of reality.”
A 2023 Wall Street Journal investigation echoed those concerns, revealing that Musk’s alleged use of cocaine, MDMA, and mushrooms at elite private events alarmed multiple board members. The public has already seen Musk indulge in drug use on record — most notably in 2018, when he famously smoked marijuana during a live podcast with Joe Rogan.
As of Friday, Musk was still scheduled to appear at a White House press conference alongside Donald Trump. The White House has not commented on the recent drug allegations.
With government roles, top-secret access, and influence over national policy, Musk’s personal choices now face more scrutiny than ever. These explosive revelations raise urgent questions about fitness for leadership — in both the boardroom and the halls of power.
